FDA Inspection 1131813 — Angela Gibson, MD, PhD
The FDA completed an inspection of Angela Gibson, MD, PhD on October 9, 2020 in Madison, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 9, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Madison, WI (United States)
Additional Details
Clinical Investigator (CI)